Hepatitis B
Show Only Open Trials
1.
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection (GS-US-283-0102)
- Study Status: Open to Enrollment
- Sponsor: Gilead
- Disease Status and/or Stage: Chronic Hepatitis B
- Protocol ID: GS-US-283-0102
2.
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B
- Study Status: Open to Enrollment
- Sponsor: Gilead Sciences, Inc.
- Disease Status and/or Stage: Chronic Hepatitis B
3.
A Phase 2a, Pilot, Open-Label Trial Evaluating the Safety, Tolerability and Pharmacodynamic Effects of GS-6624 in Subjects With Fibrosis of the Liver
- Study Status: Open to Enrollment
- Sponsor: Gilead Sciences
- Disease Status and/or Stage: Chronic Liver Disease and Liver Fibrosis of Any Cause
4.
Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
- Study Status: Closed to Enrollment
- Sponsor: Eisai Inc.
- Disease Status and/or Stage: Chronic Liver Disease
